insights_auto
Why is CSBR down 2,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,49 US$
arrow_downward
-2,21%(-0,10) 1D
18 ნოე, 10:42:24 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 US$
High
4,60 US$
Low
4,49 US$
Mkt. cap
62,52 მლნ.
Avg. vol.
7,41 ათ.
Volume
3,47 ათ.
52-wk high
8,31 US$
52-wk low
4,49 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,55 US$
High
4,60 US$
Low
4,49 US$
Mkt. cap
62,52 მლნ.
Avg. vol.
7,41 ათ.
Volume
3,47 ათ.
52-wk high
8,31 US$
52-wk low
4,49 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
TradingView
·
31 წუთის წინ
S&P 500, Nasdaq find footing as Nvidia treads water
Coinpaper
·
1 საათის წინ
Dow Jones: Wall Street Eyes Rebound as Morgan Stanley Targets S&P 500 at 8,700
CNBC
·
55 წუთის წინ
The key S&P 500 level Wall Street is watching
FOREX.com
·
4 საათის წინ
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com